HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners [NA]
The clinical trial update notes the completion of Project POWER and the adapting Project SAFE, studies evaluating strategies to reduce STD/H…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. [Phase 4]
This Phase 4 trial assessed substituting raltegravir for nucleoside reverse transcriptase inhibitors in a boosted atazanavir HIV regimen. Th…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients [Phase 2]
Phase 2 trial evaluating the antiviral activity of TMC310911 when co-administered with ritonavir in treatment-naive HIV-1 infection; the stu…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216). [Phase 3]
An open-label Phase 3 trial evaluating TMC125 (rilpivirine) in HIV-1 patients virologically failing DUET trials, with results posted after s…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) [Phase 3]
Phase 3 trial comparing DB289 to trimethoprim-sulfamethoxazole for acute Pneumocystis jirovecii pneumonia has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects [Phase 4]
Phase 4 trial results assess mitochondrial effects when switching HIV patients from Combivir or Trizivir to Truvada, with results posted in …
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Motiv82Change: an HIV Prevention Study for Young Latino Men [NA]
The Motiv82Change HIV prevention trial for young Latino men has completed.
-
CLINICAL_TRIALS research · 2013-03-01Clinical Trial Update: Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda [NA]
This clinical trial update reports on alcohol use and risky sexual behaviors among HIV-infected subjects in Kampala, Uganda; the study statu…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA®) and Virologic Response to a CCR5 Antagonist in the Short Term [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial evaluating a phenotypic co-receptor test (Trofile ESTA) and the short-term virologic response to a CCR5 a…
-
FDA approval · 2013-02-27FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
FDA approves a supplemental NDA for Etravirine submitted by Patriot Pharmaceuticals.
-
FDA approval · 2013-02-22FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP. This action approves changes to the p…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection [Phase 1]
A Phase I study evaluating the safety and tolerability of the Modified Vaccinia Virus Ankara–based HIV vaccine candidate MVA-B in healthy vo…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism [Phase 4]
This update reports on a Phase 4 trial examining how two standard initial antiretroviral therapy combinations affect lipid metabolism in HIV…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl [Phase 4]
This clinical trial update notes the completion of a Phase 4 study evaluating a once-daily antiretroviral therapy regimen in HIV-1 infected …
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients [Phase 2]
A Phase 2 study comparing four dosing regimens of GW810781 with placebo in HIV-infected patients has completed. The sponsor is GlaxoSmithKli…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting
A completed clinical trial evaluating the nitrate reductase and resazurin titre assay for detecting Mycobacterium tuberculosis complex in sp…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection [NA]
This clinical trial update reports the safety and effectiveness of short-term antiretroviral therapy for people with recent HIV-1 infection.…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: HIV and Fat Accumulation [Phase 2]
Phase 2 clinical trial update on HIV infection focusing on fat accumulation; the study is completed and results were posted.
-
FDA approval · 2013-02-16FDA Approved: NEBUPENT — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for NebuPent (pentamidine isethionate) by Fresenius Kabi USA, LLC, to modify the existing approv…
-
FDA approval · 2013-02-15FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for STRIBILD (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate) from Gilea…
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) [Phase 1, Phase 2]
Phase 1/2 trial of TUTI-16 in asymptomatic HIV-1 infected subjects has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors [Phase 1]
This Phase 1 trial investigates how genetic factors influence the metabolism of non-nucleoside reverse transcriptase inhibitors in people wi…
-
FDA approval · 2013-02-14FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Selzentry (maraviroc) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2013-02-13Clinical Trial Update: Exploration of HIV Reservoirs
A completed clinical trial update on exploring HIV reservoirs.
-
CLINICAL_TRIALS research · 2013-02-13Clinical Trial Update: Attitudes and Beliefs and the Steps of HIV Care
This clinical trial update notes a completed study examining attitudes and beliefs related to the steps of HIV care.